AB Science (France) Performance
| AB Stock | EUR 1.65 0.13 7.30% |
AB Science holds a performance score of 8 on a scale of zero to a hundred. The firm owns a Beta (Systematic Risk) of 0.98, which signifies possible diversification benefits within a given portfolio. AB Science returns are very sensitive to returns on the market. As the market goes up or down, AB Science is expected to follow. Use AB Science SA mean deviation, standard deviation, treynor ratio, as well as the relationship between the downside deviation and total risk alpha , to analyze future returns on AB Science SA.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in AB Science SA are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, AB Science sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 20.7 M | |
| Total Cashflows From Investing Activities | -590 K |
AB Science |
AB Science Relative Risk vs. Return Landscape
If you would invest 102.00 in AB Science SA on November 1, 2024 and sell it today you would earn a total of 63.00 from holding AB Science SA or generate 61.76% return on investment over 90 days. AB Science SA is currently producing 1.2428% returns and takes up 10.9152% volatility of returns over 90 trading days. Put another way, 97% of traded stocks are less volatile than AB Science, and 76% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
AB Science Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for AB Science's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as AB Science SA, and traders can use it to determine the average amount a AB Science's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1139
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | AB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 10.92 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.24 actual daily | 24 76% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average AB Science is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AB Science by adding it to a well-diversified portfolio.
AB Science Fundamentals Growth
AB Science Stock prices reflect investors' perceptions of the future prospects and financial health of AB Science, and AB Science fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AB Science Stock performance.
| Return On Asset | -0.43 | |||
| Operating Margin | (12.22) % | |||
| Current Valuation | 427.66 M | |||
| Shares Outstanding | 46.86 M | |||
| Price To Earning | (10.99) X | |||
| Price To Sales | 193.66 X | |||
| Revenue | 1.61 M | |||
| EBITDA | (11.14 M) | |||
| Cash Per Share | 0.28 X | |||
| Total Debt | 14.44 M | |||
| Debt To Equity | 102.90 % | |||
| Book Value Per Share | (0.63) X | |||
| Cash Flow From Operations | (17.18 M) | |||
| Earnings Per Share | (0.43) X | |||
| Total Asset | 21.27 M | |||
| Retained Earnings | (144 M) | |||
| Current Asset | 32 M | |||
| Current Liabilities | 19 M | |||
About AB Science Performance
By analyzing AB Science's fundamental ratios, stakeholders can gain valuable insights into AB Science's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if AB Science has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if AB Science has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
AB Science S.A., a pharmaceutical company, engages in the discovery, development, and commercialization of protein kinase inhibitors for use in human and veterinary medicines. AB Science S.A. was founded in 2001 and is headquartered in Paris, France. AB SCIENCE operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. It employs 123 people.Things to note about AB Science SA performance evaluation
Checking the ongoing alerts about AB Science for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for AB Science SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| AB Science SA is way too risky over 90 days horizon | |
| AB Science SA may become a speculative penny stock | |
| AB Science SA appears to be risky and price may revert if volatility continues | |
| AB Science SA has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 1.61 M. Net Loss for the year was (14.19 M) with profit before overhead, payroll, taxes, and interest of 1.5 M. | |
| AB Science SA has accumulated about 0 in cash with (17.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28. | |
| Roughly 41.0% of the company shares are held by company insiders |
- Analyzing AB Science's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AB Science's stock is overvalued or undervalued compared to its peers.
- Examining AB Science's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AB Science's management team can have a significant impact on its success or failure. Reviewing the track record and experience of AB Science's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AB Science's stock. These opinions can provide insight into AB Science's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for AB Science Stock analysis
When running AB Science's price analysis, check to measure AB Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AB Science is operating at the current time. Most of AB Science's value examination focuses on studying past and present price action to predict the probability of AB Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AB Science's price. Additionally, you may evaluate how the addition of AB Science to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |